SynthesisBMJ open respiratory research2026
Effects of continuous positive airway pressure therapy duration on patients with obstructive sleep apnoea and type 2 diabetes mellitus: a systematic review and meta-analysis.
Synthesis in BMJ open respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWhether the efficacy of continuous positive airway pressure (CPAP) therapy differs by duration in patients with obstructive sleep apnoea (OSA) and type 2 diabetes mellitus (T2DM) is unclear. This study aimed to evaluate the effects of CPAP therapy duration on these patients.
methodsWe conducted a systematic review and meta-analysis of randomised controlled trials (RCTs) published up to 27 December 2024. We searched MEDLINE, EMBASE and the Cochrane Library for studies on patients with OSA and T2DM treated with CPAP. Outcomes of interest were haemoglobin A1c (HbA1c), fasting blood glucose (FBG), mean blood glucose (MBG), Homeostasis Model of Assessment of Insulin Resistance Index (HOMA-IR), body mass index (BMI) and Epworth Sleepiness Scale (ESS) score. Two reviewers independently screened studies, extracted data and assessed the risk of bias using the Cochrane risk of bias tool 2 tool. Data were synthesised using a random-effects model based on heterogeneity, and results were expressed as mean differences (MDs) with 95% CIs.
results14 studies enrolling 1273 participants were included in the meta-analysis. The included trials were categorised into short-term (<12 weeks), medium-term (12-<24 weeks) and long-term (≥24 weeks) based on the duration of the CPAP intervention. Analysis showed that long-term CPAP intervention was associated with a significant reduction in HOMA-IR levels (MD -1.67; 95% CI -2.57 to -0.77). CPAP was associated with increases in BMI levels after medium-term (MD 0.31 kg/m
conclusionEvidence from multiple RCTs indicates that the efficacy of CPAP therapy varies with treatment duration in patients with OSA and T2DM, showing benefits for insulin resistance and sleepiness with longer use but no significant effect on key glycaemic markers. TRIAL REGISTRATION NUMBER: The study protocol was prospectively registered with PROSPERO (https://www.crd.york.ac.uk/) (registration number: CRD42025633203).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.